Patents by Inventor Mohamed Machwate

Mohamed Machwate has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6586457
    Abstract: The present invention relates to methods for inhibiting bone resorption in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of an EP4 receptor subtype antagonist.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: July 1, 2003
    Assignees: Merck & Co., Inc., Merck Frosst Canada & Co.
    Inventors: Shun-Ichi Harada, Mohamed MacHwate, Gideon A. Rodan, Marc Labelle, Kathleen Metters, Robert N. Young
  • Patent number: 6414006
    Abstract: The present invention relates to methods for inhibiting bone resorption in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of an EP4 receptor subtype antagonist.
    Type: Grant
    Filed: October 13, 1999
    Date of Patent: July 2, 2002
    Assignees: Merck Frosst Canada & Co., Merck & Co., Inc.
    Inventors: Shun-ichi Harada, Gideon A. Rodan, Mohamed Machwate, Marc LaBelle, Kathleen Metters, Robert N. Young
  • Publication number: 20020082287
    Abstract: The present invention relates to methods for inhibiting bone resorption in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of an EP4 receptor subtype antagonist.
    Type: Application
    Filed: October 13, 1999
    Publication date: June 27, 2002
    Inventors: SHUN-ICHI HARADA, GIDEON A. RODAN, MOHAMED MACHWATE, MARC LABELLE, KATHLEEN METTERS, ROBERT N. YOUNG
  • Publication number: 20020004495
    Abstract: The present invention relates to methods for stimulating bone formation in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of an EP4 receptor subtype agonist.
    Type: Application
    Filed: July 3, 2001
    Publication date: January 10, 2002
    Inventors: Shun-Ichi Harada, Gideon A. Rodan, Mohamed Machwate, Marc Labelle, Kathleen Metters, Robert N. Young, Miron Weinreb
  • Publication number: 20010018433
    Abstract: The present invention relates to methods for inhibiting bone resorption in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of an EP4 receptor subtype antagonist.
    Type: Application
    Filed: March 26, 2001
    Publication date: August 30, 2001
    Applicant: Merck & Co., Inc.
    Inventors: Shun-Ichi Harada, Mohamed Machwate, Gideon A. Rodan, Marc Labelle, Kathleen Metters, Robert N. Young
  • Publication number: 20010012838
    Abstract: The present invention relates to methods for inhibiting bone resorption in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of an EP4 receptor subtype antagonist.
    Type: Application
    Filed: March 26, 2001
    Publication date: August 9, 2001
    Applicant: Merck & Co., Inc.
    Inventors: Shun-Ichi Harada, Mohamed MacHwate, Gideon A. Rodan, Marc Labelle, Kathleen Metters, Robert N. Young
  • Publication number: 20010006980
    Abstract: The present invention relates to methods for stimulating bone formation in a mammal comprising administering to a mammal in need thereof a therapeutically effective amount of an EP4 receptor subtype agonist.
    Type: Application
    Filed: October 13, 1999
    Publication date: July 5, 2001
    Inventors: SHUN-ICHI HARADA, MOHAMED MACHWATE, GIDEON A. RODAN, MARC LABELLE, KATHLEEN METTERS, ROBERT N. YOUNG, MIRON WEINREB